"Today's patient workflows are siloed and broken," said Banerjee. "A patient of arrhythmia is always worried even if their consumer ECG device doesn't specifically indicate they are having an episode and they tend to rush to the ED regardless. Patients with arrhythmia/atrial fibrillation are usually frequent flyers to the ED, and 30% of these visits are avoidable. Providers are also inundated by ECGs sent by emails or just phone calls from worried patients. With the AliveCor ECGs in MUSE, patients can replace their fear with confidence — confidence that their physicians have direct access to the ECGs they take at home with their KardiaMobile 6L device."

Additionally, the combination of both technologies adds to GE’s Edison platform functions, which are designed to enhance efficiency, improve patient outcomes and experiences and increase access to care.

“Delivering medically validated ECG readings taken with KardiaMobile 6L directly into MUSE can help facilitate closer connection and better communication about treatment and care between physicians and their patients, even when they are not physically together,” said Priya Abani, CEO of AliveCor, in a statement. “This integration directly supports our mission of transforming cardiology with intelligent, highly personalized heart data and connected cardiac care services by offering providers information that can be integrated seamlessly into their clinical practices, and patients the convenience, privacy, and reliability of ECG readings they can perform at home or on the go.”

Back to HCB News

Cardiology Homepage